These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10512601)

  • 1. Fluoxetine efficacy in menopausal women with and without estrogen replacement.
    Amsterdam J; Garcia-España F; Fawcett J; Quitkin F; Reimherr F; Rosenbaum J; Beasley C
    J Affect Disord; 1999 Sep; 55(1):11-7. PubMed ID: 10512601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women.
    Rasgon NL; Altshuler LL; Fairbanks LA; Dunkin JJ; Davtyan C; Elman S; Rapkin AJ
    J Clin Psychiatry; 2002; 63 Suppl 7():45-8. PubMed ID: 11995778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group.
    Schneider LS; Small GW; Hamilton SH; Bystritsky A; Nemeroff CB; Meyers BS
    Am J Geriatr Psychiatry; 1997; 5(2):97-106. PubMed ID: 9106373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
    Amsterdam JD; Garcia-España F; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Schweizer E; Beasley C
    J Clin Psychopharmacol; 1998 Dec; 18(6):435-40. PubMed ID: 9864074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
    Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
    J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R; Hosseini M; Ghanizadeh A; Ghaleiha A; Tabrizi M; Raznahan M; Golalizadeh M; Akhondzadeh S
    Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.
    Cassano P; Soares CN; Cusin C; Mascarini A; Cohen LS; Fava M
    Psychother Psychosom; 2005; 74(6):362-5. PubMed ID: 16244512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
    Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
    Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
    Cassano P; Soares CN; Cohen LS; Lyster AK; Fava M
    Arch Womens Ment Health; 2004 Jul; 7(3):167-71. PubMed ID: 15241662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
    Ferreri M; Lavergne F; Berlin I; Payan C; Puech AJ
    Acta Psychiatr Scand; 2001 Jan; 103(1):66-72. PubMed ID: 11202131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.
    Thase ME; Gelenberg A; Kornstein SG; Kocsis JH; Trivedi MH; Ninan P; Li T; Pedersen R; Keller M
    J Psychiatr Res; 2011 Mar; 45(3):412-20. PubMed ID: 20801464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.